Cutaneous Amyloidosis Associated with Autoimmune Hepatitis-Primary Biliary Cirrhosis Overlap Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

Cutaneous Amyloidosis Associated with Autoimmune Hepatitis-Primary Biliary Cirrhosis Overlap Syndrome CASE REPORT May-June, Vol. 14 No. 3, 2015: 416-419 Cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome Emmanuel I. González-Moreno,* Carlos R. Cámara-Lemarroy,** David O. Borjas-Almaguer,** Sylvia A. Martínez-Cabriales,*** Jonathan Paz-Delgadillo,* Rodrigo Gutiérrez-Udave,* Ana S. Ayala-Cortés,*** Jorge Ocampo-Candiani,*** Carlos A. Cortéz-Hernández,* Héctor J. Maldonado-Garza* * Servicio de Gastroenterología, ** Departamento de Medicina Interna, *** Servicio de Dermatología. Hospital Universitario Dr. José E. González. Universidad Autónoma de Nuevo León. Monterrey, N.L. México. ABSTRACT Cutaneous amyloidosis is a rare disease characterized by the deposition of amyloid in the dermis. It can be primary or secondary, depending on associated diseases. It has been linked to various autoimmune diseas- es, including primary biliary cirrhosis. We present the case of a patient with an autoimmune hepatitis-pri- mary biliary cirrhosis overlap syndrome with concomitant cutaneous amyloidosis, a very unusual association, and discuss similar cases and possible pathophysiological implications. Key words. Amyloid. Autoimmunity. Cholestasis. Pruritus. INTRODUCTION CASE REPORT Amyloidosis can be classified as either systemic or A 36-years-old male patient presents with pruritic cutaneous, with both primary and secondary forms. papules with brownish pigmentation of his arms for Histopathologic evidence of extracellular deposition 5 months. The patient also referred 3 months with of amyloid protein (apple-green birefringence in Con- icteric jaundice, acholia and choluria. During this go red stained slides under polarized light) within period, the patient reported no fever, use of medica- the dermis is the prominent characteristic of cutane- tions or blood transfusions. On physical examination ous amyloidoses.1,2 Autoimmune hepatitis (AIH), there were several hyperpigmented papules super primary biliary cirrhosis (PBC) and primary sclero- imposed upon macular areas over extensor surfaces sing cholangitis (PSC) are the three main variants of arms and legs, also hyperpigmented macules with of autoimmune liver disease, and when patients a rippled appearance on upper chest and upper back present with clinical, biochemical or histopathologi- (Figures 1A and 1B). A painless liver with a thick cal features of more that one of these entities, they edge 1 cm below the right costal margin was noted. are called overlap syndromes.3,4 We present a case of No evidence of chronic liver disease. a patient showing AIH-PBC overlap syndrome and Laboratory exams revealed: simultaneous primary localized cutaneous amyloido- sis (PLCA), an extremely rare association. • Total bilirubin = 6.2 mg/dL (normal value: 1.0 mg/dL). • Direct bilirubin = 3.4 mg/dL (0.4 mg/dl). • Gamma-glutamyltransferase = 849 U/l (30 U/l), and • Alkaline phosphatase = 767 U/l (250 U/l). • Alanine aminotransferase = 254 U/I (48 U/I) and Correspondence and reprint request: Emmanuel I. González-Moreno, M.D. • Aspartate aminotransferase = 231 U/I (49U/I). Servicio de Gastroenterología. Hospital Universitario Dr. José E. González. Universidad Autónoma de Nuevo León. Monterrey, N.L. México. Madero y Gonzalitos S/N, Monterrey, Nuevo León. 64460 México. Serology for hepatitis A, B and C was negative, Tel./Fax: (+52) 818333-7798 and the iron store profile was normal. Ultrasound of E-mail: [email protected] the liver only showed a homogeneous liver in the ab- Manuscript received: August 18, 2014. sence of biliary lithiasis or dilatation of the bile Manuscript accepted: October 01, 2014. ducts. 417 Cutaneous amyloidosis associated with AIH-PBC overlap syndrome. , 2015; 14 (3): 416-419 Skin biopsy with Congo red staining revealed an may co-exist in the same patient and is known as apple-green birefringence under polarized light (Fig- biphasic amyloidosis. Systemic amyloidosis, famil- ure 1C). These lesions were diagnosed as the macu- ial and hemodialysis-associated amyloidosis are lar form of PLCA. may also present with skin involvement.5,6 Nodular Determination of serum anti-mitochondrial anti- amyloidosis typically presents as crusted nodules body (AMA) and anti-smooth muscle antibody on the face, acral sites or the extremities. Macular (ASMA) was positive (1:320). amyloidosis is characterized by brownish macules The patient was submitted to a percutaneous liv- in a rippled pattern, distributed predominantly over er biopsy to rule out hepatic involvement with depo- the trunk and extremities. Papular amyloidosis sition of amyloid material. The liver biopsy showed present as pruriginous brownish papular eruptions non-suppurative destructive cholangitis with ducto- in the trunk and extremities and characterized by penia with interface hepatitis and the absence of an amyloid deposits in the papillary derma.1,2 amyloid deposit after staining with Congo red (Fig- AIH, PBC and PSC are the three main variants ures 2A and 2B). of autoimmune liver disease, and can all present as The patient was treated with a combination of ur- overlap syndromes.3,4 The AIH-PBC overlap syn- sodeoxycholic and prednisone. Unfortunately, there drome is the most common form, affecting almost the patient did no show to the follow-up visits. 10% of adults with AIH or PBC.3,4 Overlap syn- dromes show a very aggressive course, rapidly pro- DISCUSSION gressing to liver cirrhosis and liver failure without prompt diagnosis and treatment. Primary localized cutaneous amyloidosis (PLCA) Although rarely there can be cases of isolated consists of the deposition of amyloid in previously deposition of amyloid in the liver (primary hepatic healthy skin with no systemic involvement, and is amyloidosis), both immune and non-immune mediat- usually classified into three major forms, lichen ed liver diseases have also been associated with amyloidosis, the commonest type, macular, and a PLCA. While chronic hepatitis C virus infection has rare nodular form.1,2 Macular and papular forms been reported to co-occur in at least two cases, sug- gesting it could consist in another extrahepatic manifestation,7,8 hepatitis B infection has only been associated with systemic amyloidosis to date.9 A case of nodular cutaneous amyloidosis in a patient with chronic alcoholic liver cirrhosis has also been recently reported.10 However, an important associa- tion between amyloidosis and autoimmune liver dis- eases has been recognized recently. Systemic AA amyloidosis has been associated with PBC11,12 and PSC.13,14 There is only one case in the published lit- erature associating PBC and cutaneous amyloidosis in a 41 year old woman.15 AB Figure 1. Poorly delimited hyperpigmented macules pre- dominating on the trunk and limbs (A, B). Histopathological features of skin biopsy showing amorphous eosinophilic mate- Figure 2. Liver biopsy shows non-suppurative, destructive rial in the dermis and an apple-green birefringence under po- cholangitis wit ductopenia and interface hepatitis. There is an larized light with Congo red staining. absence of an amyloid deposit after staining with Congo red. 418 González-Moreno EI, et al. , 2015; 14 (3): 416-419 The precise pathogenesis of PLCA has not been and/or azathioprine, according to the course of dis- elucidated, but an increasing number of reports in ease.3,4 Liver transplantation is the treatment of the literature have associated it to autoimmune dis- choice in the setting of end-stage liver disease. Our orders, which suggests the possibility of a common patient was treated with a combination of ursodeox- underlying immune-mediated mechanism.16 Condi- ycholic and prednisone; however, a very important tions as diverse as Sjogren, Behcet, IgA nephropa- limitation in this case is that the patient did not thy, systemic lupus erythematosus and systemic show to follow-up consultations, thereby, we could sclerosis have been associated with PLCA.16-19 Nod- not evaluate the effect of treatment. ular cutaneous amyloidosis results from extra-cellu- lar deposition of fibril-forming monoclonal CONFLICT OF INTEREST immunoglobulin-derived light chains produced by a small plasma cell clone, and in systemic amyloidosis The authors declare no conflict of interest. the average plasma cell bone marrow infiltration is All authors read and approved the final manu- 7%. Abnormal folding of the light chains leads to script. amyloid deposition. In macular and papular amy- loidosis, an accepted theory is that amyloid could REFERENCES derive from apoptotic keratinocyte-released cytoker- 1,2 1. Borowicz J, Gillespie M, Miller R. Cutaneous amyloidosis. atin degradation. Skinmed 2011; 9: 96-100; quiz 1. It has been shown that cultivated keratinocytes 2. Schreml S, Szeimies RM, Vogt T, Landthaler M, Schroeder are damaged by bilirubin, and hyperbilirubinemia J, Babilas P. Cutaneous amyloidoses and systemic amy- can lead to widespread epidermal injury.20 In our loidoses with cutaneous involvement. Eur J Dermatol 2010; 20: 152-60. case, we surmise that bilirubin deposition in skin 3. Rust C, Beuers U. Overlap syndromes among autoimmune could have led to keratinocyte apoptosis and cytok- liver diseases. World J Gastroenterol 2008; 14: 3368- eratin release, leading to amyloid production. Inter- 73. estingly, overlap liver autoimmune diseases are also 4. Durazzo M, Premoli A, Paschetta E, Belci P, Spandre M, Bo S. Overlap syndromes of autoimmune hepatitis: an open associated to alterations in plasma cells and in im- question. Dig Dis Sci 2013; 58: 344-8. munoglobulin production. Besides a chronic hepati- 5. Desport
Recommended publications
  • Heme Catabolism & Jaundice
    Click to edit Master title style • Edit Master text styles • Second level • Third level Heme• Fourth level catabolism • Fifth level Dr. Marian Maher Lecturer of Biochemistry and Molecular Biology Catabolism of Heme After RBCs reach the end of their life span ( average 120 days), they are phagocytosed by reticulo- endothelial cells of liver, spleen and bone marrow. Hemoglobin is degraded first into globin and heme 1-Oxidation of Heme : a- Heme is degraded by microsomal enzyme; of the reticuloendothelial cells of liver, spleen and bone marrow which requires molecular oxygen and NADPH b- It catalyzes the cleavage of α methenyl bridge between the pyrrole rings I and II to from biliverdin with the release of carbon monoxide CO. c- Iron is liberated from heme d- In mammals, biliverdin is further reduced to bilirubin by NADPH – dependent biliverdin reductase. 2- Transport of Bilirubin: Bilirubin is slightly soluble in plasma. It transported to the liver by non covalent binding to albumin forming hemobilirubin (unconjugated or indirect bilirubin). Liver uptake bilirubin by carrier mediated transport. 3- Uptake of bilirubin by liver: The solubility of bilirubin increase by conjugating with 2 molecules of glucuronic acid to form bilirubin diglucuronide (conjugated or direct bilirubin). This reaction is catalyzed by glucuronosyl transferase enzyme 4- Excretion of conjugated bilirubin: The conjugated bilirubin secreted with the bile into intestine (the unconjugated bilirubin not 90% secreted) where it is hydrolyzed and reduced by By bacteria the gut bacteria to urobilinogen (colorless 10% compound). Most of urobilinogen is oxidized by intestinal bacteria to stercobilin, which give feces the characteristic brown color.
    [Show full text]
  • Acute Liver Failure by Autoimmune Hepatitis (AIH) and Liver Cirrhosis in Adolescent Patient: Case Report
    Open Access Austin Journal of Gastroenterology Case Report Acute Liver Failure by Autoimmune Hepatitis (AIH) and Liver Cirrhosis in Adolescent Patient: Case Report Zamarripa VL1, Valdez PRA1, Ramirez LDH1, Barrios OC1 and Ochoa MC2* Abstract 1Department of Family Medicine, Family Medicine Unit Autoimmune hepatitis (AIH) is defined as chronic liver parenchyma #1 (IMSS), Mexico inflammation of unknown etiology. In pathogenesis are involved environmental 2Department of Pediatrics, Regional General Hospital #1 triggers and immunological tolerance in genetically predisposed patients (IMSS), Mexico resulting in liver parenchymal attack by T lymphocytes. For diagnosis, histologic *Corresponding author: Ochoa Maria Citlaly, features and specific analytic are required (hypergammaglobulinemia and Department of Pediatrics, Regional General Hospital specific autoantibody), disease is classified as type 1 (ANA and/or SMA and/ #1 (IMSS), Sonora Delegation, Sonora, México, Colonia or SLA positive) and type 2 (LKM-1 and/or LC1 positive).In few cases AIH centro, Cd. Obregon, Sonora, Mexico remission is acquired, main goal of treatment is to modify natural history, relieve symptoms, improve biochemical parameters and decrease liver tissue Received: July 18, 2016; Accepted: August 17, 2016; inflammation and fibrosis. We report a 19 years old female with acute liver failure Published: August 19, 2016 secondary to relapse autoimmune hepatitis and liver cirrhosis with a clinical course of 16 years in maintenance treatment with prednisone who presented multiple complications. Keywords: Autoimmune hepatitis; Acute liver failure; Adolescence Introduction nodules, steatosis and portal hypertension. She was hospitalized and laboratory tests reported (Table 1): cholesterol 100 mg; total protein First autoimmune hepatitis reference was in 1942 known as lupus 7.6 g; albumin 3.2 g; globulin 5.5 g; direct bilirubin 1.8 mg; indirect hepatitis [1].
    [Show full text]
  • Bile Cast Nephropathy Secondary to Hemophagocytic Lymphohistiocytosis with Liver Failure
    Open Access Case Report DOI: 10.7759/cureus.10226 Bile Cast Nephropathy Secondary to Hemophagocytic Lymphohistiocytosis With Liver Failure Juan Jose Chango Azanza 1 , Nerea Lopetegui Lia 1 , Paola Michelle Calle Sarmiento 2 1. Internal Medicine, University of Connecticut School of Medicine, Farmington, USA 2. Internal Medicine, Catholic University of Cuenca, Cuenca, ECU Corresponding author: Juan Jose Chango Azanza, [email protected] Abstract Acute kidney injury (AKI) is a common complication seen in patients with hemophagocytic lymphohistiocytosis (HLH). More than half of patients with HLH require renal replacement therapy (RRT). There are four main causes of kidney dysfunction in HLH, which include acute tubular necrosis (ATN), hypoperfusion, tumor lysis syndrome (TLS), and HLH-related glomerulopathies. Bile cast nephropathy (BCN) is a known cause of kidney injury in patients with liver failure and hyperbilirubinemia. We present the case of a 58-year-old man who presented to the hospital with painless jaundice, choluria, acholia, and generalized malaise and was found to have hyperbilirubinemia and kidney injury in the setting of HLH, who underwent a renal biopsy showing bile salt casts with degenerating tubular lining cells consistent with BCN. This case highlights the importance of considering BCN as a cause of kidney injury when a patient with HLH presents with liver failure and elevated bilirubin levels. Categories: Nephrology, Oncology, Hematology Keywords: bile salt nephropathy, cholemic nephropathy, hemophagocytic lymphohistiocytosis (hlh) Introduction Hemophagocytic lymphohistiocytosis (HLH) is a rare and devastating disorder in which an uncontrolled activation of the immune system, in particular the hematophagocytic histiocytes, provokes a cytokine storm and multiorgan failure [1]. It has been recognized that acute kidney injury (AKI) can occur in HLH due to acute tubular necrosis (ATN) (49%), hypoperfusion (46%), tumor lysis syndrome (TLS) (29%), and HLH- related glomerulopathies (17%) [2].
    [Show full text]
  • Sickle Cell Intrahepatic Cholestasis Unresponsive to Exchange
    rev bras hematol hemoter. 2 0 1 7;3 9(2):163–166 Revista Brasileira de Hematologia e Hemoterapia Brazilian Journal of Hematology and Hemotherapy www.rbhh.org Case Report Sickle cell intrahepatic cholestasis unresponsive to exchange blood transfusion: a case report ∗ Juliana Albano de Guimarães, Luciana Cristina dos Santos Silva Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte, MG, Brazil a r t i c l e i n f o Article history: Received 7 September 2016 Accepted 15 February 2017 Available online 11 March 2017 Introduction Case report Sickle cell intrahepatic cholestasis (SCIC) is an uncom- The patient was a 38-year-old Afro-Brazilian woman with SCD mon but severe complication in sickle cell disease (SCD) (Hb SS) and a medical history of complications of her disease: patients homozygous for hemoglobin (Hb) S or with Hb acute painful vaso-occlusive crises, bone infarcts, skin ulcer of 1–3 S/␤ thalassemia. It is clinically characterized by marked the lower limb, acute chest syndrome and autosplenectomy. conjugated hyperbilirubinemia, right upper quadrant pain, She had no history of alcohol abuse and had a normal body enlarged liver and moderately elevated hepatic enzymes. In mass index. She complained of jaundice, choluria, dyspnea more severe cases, coagulopathy and renal dysfunction may on light exertion and pain in the right upper abdominal quad- be observed and the condition occasionally progresses to rant and in the lower limbs that started four months prior to liver failure. SCIC is most commonly described in its acute hospital admission. or recurrent forms but it eventually becomes chronic.
    [Show full text]
  • Manual of Laboratory Diagnosis
    Class Rf^V? i.^ Book ]0 GjpiglitlN" CDEffilGHT DEPOSm MANUAL OF LABORATORY DIAGNOSIS Compiled and Elaborated by Herman John Bollinger, S. B., M. D. Assistant in Bacteriology Johns Hopkins University Preface by Sidney R. Miller, S. B., M. D. Associate in Clinical Medicine Johns Hopkins University BALTIMORE. MD. MEDICAL STANDARD BOOK CO, iP^\^.i'^ Copyright 1919 Medical Standard Book Co. Baltimore, Md. mR "5 19 > ' Press of , The Medical Standard Book Co. Baltimore CI.A5L2476 This book is compiled irom lectures given by the following instructors at the Johns Hopkins Medical School. S. R. Miller, M. D., Lectures on Urine, and Blood. Marjorie D. Batchelor, M. D., Lectures on Stomach Analysis. F. A. Evans. M. D., Lectures on Sputum and Stools. W. A. Baetjer, M. D., and S. R. Miller, M. D., Lectures on Blood. C. G. Guthrie, M. D., Lectures on Parasites. PREFACE. Requests have come from time to time for out- lines of the general course in Clinical Microscopy, as given at the Johns Hopkins Medical School, or for summaries of the individual subjects covered. Such outlines have not any particular merit other than that they serve as guides for teaching, or compends, useful for the quick reviewing of any particular topic. It has always seemed a wiser policy to en- courage each student, carefully to take his own notes and prepare for himself such a working out- line as best suited his own needs. Condensed notes and compends in general are too prone to stimulate superficiality to warrant their unqualified recom- njendation. Moreover the practice here has been to have each instructor cover a different subject each year, thereby ^\idening the scope of each man's knowledge and interests; each improving on his predecessor's lectures, if possible.
    [Show full text]
  • 2020 Southern Regional Meeting
    Abstracts J Investig Med: first published as 10.1136/jim-2020-SRM on 28 January 2020. Downloaded from Cardiovascular club I mice is regulated through the TGF-b1-mediated SMAD- dependent pathway. 11:00 AM Thursday, February 13, 2020 2 INSULIN-LIKE GROWTH FACTOR-1 UPREGULATES JUNCTION PROTEINS, WHILE IT DOWNREGULATES 1 CARDIAC FIBROSIS AND HEART FAILURE IN MICE ADHESION PROTEINS IN VASCULAR ENDOTHELIAL CARRYING GENETIC ABLATION OF NATRIURETIC CELLS: POTENTIAL MECHANISMS FOR ANTI- PEPTIDE RECEPTOR-A: ROLE OF TGF-BETA1 ATHEROGENIC EFFECTS PATHWAY 1Y Higashi*, 1S Danchuk, 2Z Li, 1T Yoshida, 1S Sukhanov, 1P Delafontaine. 1Tulane H Chen, R Samivel, U Subramanian, KN Pandey*. Tulane University Health Sciences Center, University School of Medicine, New Orleans, LA; 2University of Missouri School of Medicine, New Orleans, LA Columbia, MO 10.1136/jim-2020-SRM.1 10.1136/jim-2020-SRM.2 Purpose of study Mice carrying targeted-ablation of the natriu- Purpose of study Insulin-like Growth Factor-1 (IGF-1) is an retic peptide receptor-A (NPRA) gene (Npr1) exhibit cardiac anti-atherogenic growth factor, having anti-inflammatory hypertrophy with increased collagen deposition and fibrosis. effects on macrophages and pro-survival and profibrotic The goal of this study was to determine the underlying mech- effects on vascular smooth muscle cells. However, its effects anisms that regulate the development of cardiac fibrosis and on vascular endothelial cells are not fully described. We heart failure in Npr1 gene-knockout mice. assessed IGF-1 effects on expression levels of intercellular Methods used The Npr1 null mutant (Npr1-/-, 0-copy), hetero- junction proteins and cell adhesion proteins in aortic endo- zygous (Npr1±, 1-copy), and wild-type (Npr1+/+, 2-copy) thelial cells.
    [Show full text]
  • HEMOLYSIS & JAUNDICE: an Overview
    HEMOLYSIS & JAUNDICE: An Overview University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL MBBS SEMINAR VJ Temple 1 What do you understand by Intravascular Hemolysis? • Destruction of RBC (Hemolysis) normally occurs in Reticuloendothelial system: • Extra-vascular compartment: Extravascular Hemolysis • In some diseases, Hemolysis of RBC occurs within the Vascular System: • Intravascular compartment: Intravascular Hemolysis • During Intravascular Hemolysis Free Hemoglobin and Heme are released in Plasma; 2 • Free Hb and Heme in plasma can result in their excretion via the Kidneys with substantial loss of Iron • Loss of Iron is prevented by Specific Plasma Proteins: • Transferrin, and • Haptoglobins (Hp) • Both are involved in scavenging mechanisms • Transferrin: binds and transports Iron in plasma and thus permits Reutilization of Iron; • Haptoglobins (Hp): 2-Globulins produced in the Liver; 3 What happens to Free Hb during Intravascular Hemolysis? • Sequence of events that occurs when Free Hb appears in plasma (Fig. 1): • Hb is Oxygenated in Pulmonary Capillaries, • OxyHb dissociates into -OxyHb Dimers, • -OxyHb Dimers are bound by circulating plasma Haptoglobins, • Haptoglobins have High Affinity for -OxyHb Dimers; • One molecule of Haptoglobin binds Two -OxyHb Dimers, 4 • DeoxyHb does not dissociate into Dimers under normal physiological settings, thus it is not bound by Haptoglobins; • Complex formed when Haptoglobin interacts with -OxyHb Dimers is too large to be filtered via the Glomerular Membrane; • During Intravascular Hemolysis: • Free Hb, appears in Renal Tubules and in Urine, causing Black-Water Fever, • This occurs when binding capacity of circulating Haptoglobin molecules have been exceeded; 5 Figs.
    [Show full text]
  • Liver Diseases and Pregnancy
    DOI: https://doi.org/10.22516/25007440.367 Review articles Liver diseases and pregnancy Luis Guillermo Toro1*, Elizabeth María Correa2, Luisa Fernanda Calle2, Adriana Ocampo3, Sandra María Vélez4 1. Clinical and transplant hepatologist, Master’s degree Abstract in health economics, Director of the functional unit of digestive diseases and transplantation at Hospital Liver diseases develop in 3% to 5% of all gestations. Among the causes are: 1. Physiological changes of de San Vicente Fundación in Rionegro, Antioquia, pregnancy. 2. Pre-existing liver diseases and conditions. The most common are cholestatic diseases such as Colombia primary biliary cholangitis and primary sclerosing cholangitis. Others include autoimmune hepatitis, Wilson’s 2. Clinical and transplant hepatologist at Hospital San Vicente Fundación in Medellín and Rionegro, disease, chronic viral hepatitis, cirrhosis of any etiology and histories of liver transplantation. 3. Liver disease Antioquia, Colombia acquired during pregnancy, especially viral hepatitis, drug-induced toxicity and hepatolithiasis. 4. Pregnancy- 3. General practitioner, and Master’s student in related liver diseases including hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, preeclamp- epidemiology at Hospital San Vicente Fundación in Medellín and Rionegro, Antioquia, Colombia sia, HELLP syndrome and fatty liver of pregnancy. 4. Specialist in gynecology and obstetrics and Severity ranges from absence of symptoms to acute liver failure and even death. Severe cases have department head at the Universidad de Antioquia in significant morbidity and mortality for both mother and fetus. These cases require rapid evaluation, accurate Medellin, Antioquia, Colombia diagnosis and appropriate management by a multidisciplinary team including high-risk obstetrics, hepatology, *Correspondence: Luis Guillermo Toro, gastroenterology and interventional radiology.
    [Show full text]
  • Clinical and Regulatory Protocol for the Treatment of Jaundice in Adults and Elderly Subjects: a Support for the Health Care Network
    Clinical and regulatory protocol for the treatment of jaundice in adults and elderly subjects: A support for the health care network 22-CLINICAL RESEARCH ORIGINAL ARTICLE Alimentary Tract Clinical and regulatory protocol for the treatment of jaundice in adults and elderly subjects: A support for the health care network and regulatory system1 Protocolo clínico e de regulação para o tratamento de icterícia no adulto e idoso: Subsídio para as redes assistenciais e o complexo regulador José Sebastião dos SantosI, Rafael KempII, Ajith Kumar SankarankuttyIII, Wilson Salgado JúniorIV, Fernanda Fernandes SouzaV, Andreza Correa TeixeiraVI, Guilherme Viana RosaVII, Orlando Castro-e-SilvaVIII I PhD, Professor, Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, Univesity of São Paulo, Brazil. II MD, Assistant, Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil. III PhD, Professor, Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil. IV MD, Professor, Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil. V Fellow Master degree, Member of the Liver Transplant Program of the Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil. VI Fellow Master degree, Member of the Liver Transplant Program of the Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil. VII MD. Resident, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil.
    [Show full text]
  • Evaluation of Liver Disease in the Pediatric Patient Ian D
    ARTICLE Evaluation of Liver Disease in the Pediatric Patient Ian D. D’Agata, MD* and William F. Balistreri, MD† viruses, it is not the same entity as OBJECTIVES the viral hepatitis observed in older After completing this article, readers should be able to: children and adolescents. Under- standing that specific diseases are 1. List the age-specific causes of liver disease in neonates, infants, older more common, if not exclusive, to children, and adolescents. certain age groups is of great help in 2. Explain why fractionation of serum bilirubin is necessary in infants focusing the evaluation and defining who remain jaundiced after 2 weeks of age. the cause of underlying liver dis- 3. Characterize the syndrome of “neonatal hepatitis” and explain how it ease. It is important to remember differs from viral hepatitis. 4. Characterize biliary atresia and identify findings from the history, that despite the long list of disorders physical examination, and laboratory evaluation that may suggest this associated with liver disease in the diagnosis. neonate, most are encountered 5. Describe a quick, cost-effective diagnostic approach to a neonate who rarely. Further, although lists of the presents with cholestasis. various etiologies leading to pediat- ric liver disease are extremely lengthy, about 10 diseases constitute Introduction more successful in infants who approximately 95% of all cases of cholestasis seen, and of these, bili- Because clinicians often do not rec- weigh more than 10 kg at the time of surgery. ary atresia and neonatal hepatitis are ognize the presence of underlying responsible for more than 60%. liver disease, precise documentation Unfortunately, the timely recogni- tion of severe liver disease in the In general, the clinician initially of the disorder can be delayed, suspects liver disease in the neonate which can lead to a subsequent pediatric patient remains a major problem.
    [Show full text]
  • Measurement and Clinical Usefulness of Bilirubin in Liver Disease
    Adv Lab Med 2021; 2(3): 352–361 Review Armando Raúl Guerra Ruiz*, Javier Crespo, Rosa Maria López Martínez, Paula Iruzubieta, Gregori Casals Mercadal, Marta Lalana Garcés, Bernardo Lavin and Manuel Morales Ruiz Measurement and clinical usefulness of bilirubin in liver disease https://doi.org/10.1515/almed-2021-0047 and may impair the uptake of indirect bilirubin from plasma Received December 2, 2020; accepted February 16, 2021; and diminish direct bilirubin transport and clearance published online July 9, 2021 through the bile ducts. Various analytical methods are currently available for measuring bilirubin and its metabo- Abstract: Elevated plasma bilirubin levels are a frequent lites in serum, urine and feces. Serum bilirubin is deter- clinical finding. It can be secondary to alterations in any mined by (1) diazo transfer reaction, currently, the gold- stage of its metabolism: (a) excess bilirubin production standard; (2) high-performance liquid chromatography (i.e., pathologic hemolysis); (b) impaired liver uptake, with (HPLC); (3) oxidative, enzymatic, and chemical methods; (4) elevation of indirect bilirubin; (c) impaired conjugation, direct spectrophotometry; and (5) transcutaneous methods. prompted by a defect in the UDP-glucuronosyltransferase; Although bilirubin is a well-established marker of liver and (d) bile clearance defect, with elevation of direct bili- function, it does not always identify a lesion in this organ. rubin secondary to defects in clearance proteins, or inability Therefore, for accurate diagnosis, alterations in bilirubin of the bile to reach the small bowel through bile ducts. A concentrations should be assessed in relation to patient liver lesion of any cause reduces hepatocyte cell number anamnesis, the degree of the alteration, and the pattern of concurrent biochemical alterations.
    [Show full text]